The aim of our study was to identify clinical criteria for optimizing rehabilitation of patients with unilateral deafness using the Baha device. We made a retrospective study of 102 patients with unilateral deafness requesting auditory rehabilitation over a period of 5 years. All subjects underwent a series of stereo audiometric tests, with and without Baha worn on a headband, and were then referred to a hearing care specialist for a real life trial of 15 days. The Glasgow Health Status Inventory (GHSI) questionnaire was administered. Patients refusing the implantation were retrospectively submitted to a questionnaire specifically designed to ask the reasons for refusal. We measured stereo audiometric test results, age, aetiology of deafness, duration of auditory deprivation on the rehabilitated ear, and GHSI score. At the conclusion of testing, the implantation rate was 29%. During preoperative testing, the improvement in understanding of speech-in-noise was 22 ± 11% for patients agreeing to the implantation versus 13 ± 11% for patients refusing the implantation. Age, aetiology of deafness and duration of auditory deprivation had no influence on the implantation decision. Speech-in-noise testing and aided stereo audiometric gain were the only two measures showing statistically significant differences between the groups agreeing to and refusing the implantation. There were multiple reasons for refusal of the implantation. Among these, the four principal reasons were: absence of perceived benefit during stereo audiometric testing (59%), requirement for surgery (35%), cost of the solution (44%), and aesthetics (41%). Hence, no other criteria except the preoperative improvement in understanding of speech-in-noise and the aided gain from Baha worn on a headband were found to be predictive of the patient's acceptance of surgical implantation of a bone-anchored implant/abutment for Baha. Speech-in-noise testing with and without Baha worn on a headband has a role to play in deciding on the implantation of a bone-anchored hearing solution.

Keywords:
Bone conduction device, Baha device, Unilateral deafness, Auditory rehabilitation, Stereo audiometry
1.
Bateman N, Nikolopoulos TP, Robinson K, O'Donoghue GM: Impairments, disabilities, and handicaps after acoustic neuroma surgery. Clin Otolaryngol Allied Sci 2000;25:62-65.
2.
Burkey JM, Berenholz LP, Lippy WH: Latent demand for the bone-anchored hearing aid: the Lippy Group experience. Otol Neurotol 2006;27:648-652.
3.
Hol MK, Bosman AJ, Snik AF, Mylanus EA, Cremers CW: Bone-anchored hearing aid in unilateral inner ear deafness: a study of 20 patients. Audiol Neurootol 2004;9:274-281.
4.
Hol MK, Bosman AJ, Snik AF, Mylanus EA, Cremers CW: Bone-anchored hearing aids in unilateral inner ear deafness: an evaluation of audiometric and patient outcome measurements. Otol Neurotol 2005;26:999-1006.
5.
Hol MK, Kunst SJ, Snik AF, Cremers CW: Pilot study on the effectiveness of the conventional CROS, the transcranial CROS and the BAHA transcranial CROS in adults with unilateral inner ear deafness. Eur Arch Otorhinolaryngol 2010;267:889-896.
6.
Kompis M, Pfiffner F, Krebs M, Caversaccio M-D: Factors influencing the decision in unilateral deafness: the Bern Benefit in Single-Sided Deafness Questionnaire. Adv Otorhinolaryngol 2011;71:103-111.
7.
Niparko JK, Cox KM, Lustig LR: Comparison of the bone-anchored hearing aid implantable hearing device with contralateral routing of offside signal amplification in the rehabilitation of unilateral deafness. Otol Neurotol 2003;24:73-78.
8.
Robinson K, Gatehouse S, Browning GG: Measuring patient benefit from otorhinolaryngological surgery and therapy. Ann Otol Rhinol Laryngol 1996;105:415-422.
9.
Snapp H, Angeli S, Telischi FF, Fabry D: Postoperative validation of bone-anchored implants in the single-sided deafness population. Otol Neurotol 2012;33:291-296.
10.
Vaneecloo FM, Hanson JN, Laroche C, Vincent C, Dehaussy J: Prosthetic rehabilitation of unilateral anakusis. Study with stereoaudiometry (in French). Ann Otolaryngol Chir Cervicofac 2000;117:410-417.
11.
Wazen JJ, Ghossaini SN, Spitzer JB, Kuller M: Localization by unilateral BAHA users. Otolaryngol Head Neck Surg 2005;132:928-932.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.